Logo

Integra LifeSciences Holdings Corporation

IART

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, ce… read more

Healthcare

Medical Devices

30 years

USD

Exclusive to Premium users

Price

per share adjusted in USD

$13.86

Price

+5.40%

$0.71

Market Cap

$1.080b

Small

Price/Earnings

-

Premium

3y Avg

Premium

5y Avg

Financial Reports

Key metrics over the past few years and other important metrics. Amounts in USD.

+13.4%

EBITDA Margin

-1.3%

Net Profit Margin

+6.4%

Free Cash Flow Margin

+13.4%

EBITDA Margin

-1.3%

Net Profit Margin

+6.4%

Free Cash Flow Margin
Revenue

$1.643b

+2.0%

1y CAGR

+1.8%

3y CAGR

+1.6%

5y CAGR
Earnings

-$495.335m

-7033.3%

1y CAGR

-2402.0%

3y CAGR

-1799.8%

5y CAGR
EPS

-$6.48

-7100.0%

1y CAGR

-2423.9%

3y CAGR

-1815.7%

5y CAGR
Book Value

$1.038b

$3.646b

Assets

$2.609b

Liabilities

$2.006b

Debt
Debt to Assets

55.0%

-6.4x

Debt to EBITDA
Free Cash Flow

-$14.467m

-157.9%

1y CAGR

-96.7%

3y CAGR

-77.0%

5y CAGR
No items found.
Press Releases
Statements and updates from the company
↑ TopSummaryPriceFinancialsPress Releases